Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease

NeuroImage

Volumn 40, Issue 4, 2008, Pages 1503-1515

  Habeck, Christian ^a   Foster, Norman L ^b   Perneczky, Robert ^c   Kurz, Alexander ^c   Alexopoulos, Panagiotis ^c,d   Koeppe, Robert A ^e   Drzezga, Alexander ^c   Stern, Yaakov ^a  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GERMANY; HUMAN; MULTIVARIATE ANALYSIS; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; UNIVARIATE ANALYSIS;

AGED; ALGORITHMS; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSITRON-EMISSION TOMOGRAPHY; PRINCIPAL COMPONENT ANALYSIS; RADIOPHARMACEUTICALS;

EID: 41649094769     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2008.01.056     Document Type: Article

References (53)

1. Alexander G.E., Mentis M.J., Van Horn J.D., Grady C.L., Berman K.F., Furey M.L., Pietrini P., Rapoport S.I., Schapiro M.B., and Moeller J.R. Individual differences in PET activation of object perception and attention systems predict face matching accuracy. Neuroreport 10 (1999) 1965-1971
2. Alexander G.E., Chen K., Merkley T.L., Reiman E.M., Caselli R.J., Aschenbrenner M., Santerre-Lemmon L., Lewis D.J., Pietrini P., Teipel S.J., Hampel H., Rapoport S.I., and Moeller J.R. Regional network of magnetic resonance imaging gray matter volume in healthy aging. Neuroreport 17 (2006) 951-956
3. Berg L., Miller J.P., Storandt M., Duchek J., Morris J.C., Rubin E.H., Burke W.J., and Coben L.A. Mild senile dementia of the Alzheimer type: 2. Longitudinal assessment. Ann. Neurol. 23 (1988) 477-484
4. Bozzali M., Filippi M., Magnani G., Cercignani M., Franceschi M., Schiatti E., Castiglioni S., Mossini R., Falautano M., Scotti G., Comi G., and Falini A. The contribution of voxel-based morphometry in staging patients with mild cognitive impairment. Neurology 67 (2006) 453-460
5. Braak H., Braak E., Bohl J., and Bratzke H. Evolution of Alzheimer's disease related cortical lesions. J. Neural Transm. 54 (1998) 97-106 Suppl
6. Brickman A.M., Habeck C., Zarahn E., Flynn J., and Stern Y. Structural MRI covariance patterns associated with normal aging and neuropsychological functioning. Neurobiol. Aging 28 (2007) 284-295
7. Burdette J.H., Minoshima S., Vander Borght T., Tran D.D., and Kuhl D.E. Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology 198 (1996) 837-843
8. Burnham K.P., and Anderson D.R. Model Selection and Multimodel Inference (2002), Springer Verlag, New York
9. Carbon M., Trost M., Ghilardi M.F., and Eidelberg D. Abnormal brain networks in primary torsion dystonia. Adv. Neurol. 94 (2004) 155-161
10. Chetelat G., Desgranges B., de la Sayette V., Viader F., Berkouk K., Landeau B., Lalevee C., Le Doze F., Dupuy B., Hannequin D., Baron J.C., and Eustache F. Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain 126 (2003) 1955-1967
11. Chetelat G., Desgranges B., de la Sayette V., Viader F., Eustache F., and Baron J.C. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease?. Neurology 60 (2003) 1374-1377
12. Chetelat G., Landeau B., Eustache F., Mezenge F., Viader F., de la Sayette V., Desgranges B., and Baron J.C. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 27 (2005) 934-946
13. Davatzikos C., Fan Y., Wu X., Shen D., and Resnick S.M. Detection of prodromal Alzheimer's disease via pattern classification of MRI. Neurobiol. Aging (2006)
14. de Leon M.J., Convit A., Wolf O.T., Tarshish C.Y., DeSanti S., Rusinek H., Tsui W., Kandil E., Scherer A.J., Roche A., Imossi A., Thorn E., Bobinski M., Caraos C., Lesbre P., Schlyer D., Poirier J., Reisberg B., and Fowler J. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-d-glucose/poitron-emission tomography (FDG/PET). Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 10966-10971
15. Delieu J., and Keady J. The biology of Alzheimer's disease: 1. Br. J. Nurs. 5 (1996) 162-168
16. Devanand D.P., Habeck C.G., Tabert M.H., Scarmeas N., Pelton G.H., Moeller J.R., Mensh B.D., Tarabula T., Van Heertum R.L., and Stern Y. PET network abnormalities and cognitive decline in patients with mild cognitive impairment. Neuropsychopharmacology 31 (2006) 1327-1334
17. Drzezga A., Riemenschneider M., Strassner B., Grimmer T., Peller M., Knoll A., Wagenpfeil S., Minoshima S., Schwaiger M., and Kurz A. Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology 64 (2005) 102-107
18. Efron B., and Tibshirani R.J. An Introduction to the Bootstrap (1994), CRC Press, LLC, New York
19. Eidelberg D., Dhawan V., Moeller J.R., Sidtis J.J., Ginos J.Z., Strother S.C., Cederbaum J., Greene P., Fahn S., Powers J.M., et al. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. J. Neurol. Neurosurg. Psychiatry 54 (1991) 856-862
20. Eidelberg D., Moeller J.R., Kazumata K., Antonini A., Sterio D., Dhawan V., Spetsieris P., Alterman R., Kelly P.J., Dogali M., Fazzini E., and Beric A. Metabolic correlates of pallidal neuronal activity in Parkinson's disease. Brain 120 Pt 8 (1997) 1315-1324
21. Engler H., Forsberg A., Almkvist O., Blomquist G., Larsson E., Savitcheva I., Wall A., Ringheim A., Langstrom B., and Nordberg A. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 129 (2006) 2856-2866
22. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975) 189-198
23. Foster N.L., Heidebrink J.L., Clark C.M., Jagust W.J., Arnold S.E., Barbas N.R., DeCarli C.S., Turner R.S., Koeppe R.A., Higdon R., and Minoshima S. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain 130 (2007) 2616-2635
24. Greicius M.D., Srivastava G., Reiss A.L., and Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4637-4642
25. Herholz K., Salmon E., Perani D., Baron J.C., Holthoff V., Frolich L., Schonknecht P., Ito K., Mielke R., Kalbe E., Zundorf G., Delbeuck X., Pelati O., Anchisi D., Fazio F., Kerrouche N., Desgranges B., Eustache F., Beuthien-Baumann B., Menzel C., Schroder J., Kato T., Arahata Y., Henze M., and Heiss W.D. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 17 (2002) 302-316
26. Higdon R., Foster N.L., Koeppe R.A., DeCarli C.S., Jagust W.J., Clark C.M., Barbas N.R., Arnold S.E., Turner R.S., Heidebrink J.L., and Minoshima S. A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging. Stat. Med. 23 (2004) 315-326
27. Huang C., Eidelberg D., Habeck C., Moeller J., Svensson L., Tarabula T., and Julin P. Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT. Neurobiol. Aging 28 (2007) 1062-1069
28. Hughes A.J., Ben-Shlomo Y., Daniel S.E., and Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 42 (1992) 1142-1146
29. Hutchinson M., Nakamura T., Moeller J.R., Antonini A., Belakhlef A., Dhawan V., and Eidelberg D. The metabolic topography of essential blepharospasm: a focal dystonia with general implications. Neurology 55 (2000) 673-677
30. Ishii K., Sasaki M., Yamaji S., Sakamoto S., Kitagaki H., and Mori E. Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease. J. Nucl. Med. 39 (1998) 293-298
31. Jagust W.J., Eberling J.L., Wu C.C., Finkbeiner A., Mungas D., Valk P.E., and Haan M.N. Brain function and cognition in a community sample of elderly Latinos. Neurology 59 (2002) 378-383
32. Kasama S., Tachibana H., Kawabata K., and Yoshikawa H. Cerebral blood flow in Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease according to three-dimensional stereotactic surface projection imaging. Dement. Geriatr. Cogn. Disord. 19 (2005) 266-275
33. 18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis. J. Cereb. Blood Flow Metab. 26 (2006) 1213-1221
34. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N., Ballard C., de Vos R.A., Wilcock G.K., Jellinger K.A., and Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47 (1996) 1113-1124
35. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
36. Meguro K., Blaizot X., Kondoh Y., Le Mestric C., Baron J.C., and Chavoix C. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease. Brain 122 Pt 8 (1999) 1519-1531
37. Minoshima S., Cross D.J., Foster N.L., Henry T.R., and Kuhl D.E. Discordance between traditional pathologic and energy metabolic changes in very early Alzheimer's disease. Pathophysiological implications. Ann. N. Y. Acad. Sci. 893 (1999) 350-352
38. Moeller J.R., Strother S.C., Sidtis J.J., and Rottenberg D.A. Scaled subprofile model: a statistical approach to the analysis of functional patterns in positron emission tomographic data. J. Cereb. Blood Flow Metab. 7 (1987) 649-658
39. Moeller J.R., Ishikawa T., Dhawan V., Spetsieris P., Mandel F., Alexander G.E., Grady C., Pietrini P., and Eidelberg D. The metabolic topography of normal aging. J. Cereb. Blood Flow Metab. 16 (1996) 385-398
40. Nakamura T., Ghilardi M.F., Mentis M., Dhawan V., Fukuda M., Hacking A., Moeller J.R., Ghez C., and Eidelberg D. Functional networks in motor sequence learning: abnormal topographies in Parkinson's disease. Hum. Brain Mapp. 12 (2001) 42-60
41. Nakano S., Asada T., Yamashita F., Kitamura N., Matsuda H., Hirai S., and Yamada T. Relationship between antisocial behavior and regional cerebral blood flow in frontotemporal dementia. Neuroimage 32 (2006) 301-306
42. Neary D., Snowden J.S., Gustafson L., Passant U., Stuss D., Black S., Freedman M., Kertesz A., Robert P.H., Albert M., Boone K., Miller B.L., Cummings J., and Benson D.F. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51 (1998) 1546-1554
43. Nichols L., Pike V.W., Cai L., and Innis R.B. Imaging and in vivo quantitation of beta-amyloid: an exemplary biomarker for Alzheimer's disease?. Biol. Psychiatry 59 (2006) 940-947
44. Pearson R.C. Cortical connections and the pathology of Alzheimer's disease. Neurodegeneration 5 (1996) 429-434
45. Rubin E.H., Kinscherf D.A., and Morris J.C. Psychopathology in younger versus older persons with very mild and mild dementia of the Alzheimer type. Am. J. Psychiatry 150 (1993) 639-642
46. Scarmeas N., Habeck C.G., Zarahn E., Anderson K.E., Park A., Hilton J., Pelton G.H., Tabert M.H., Honig L.S., Moeller J.R., Devanand D.P., and Stern Y. Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance. Neuroimage 23 (2004) 35-45
47. Teipel S.J., Flatz W.H., Heinsen H., Bokde A.L., Schoenberg S.O., Stockel S., Dietrich O., Reiser M.F., Moller H.J., and Hampel H. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. Brain 128 (2005) 2626-2644
48. Thomann P.A., Wustenberg T., Pantel J., Essig M., and Schroder J. Structural changes of the corpus callosum in mild cognitive impairment and Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 21 (2006) 215-220
49. Trollor J.N., Sachdev P.S., Haindl W., Brodaty H., Wen W., and Walker B.M. Regional cerebral blood flow deficits in mild Alzheimer's disease using high resolution single photon emission computerized tomography. Psychiatry Clin. Neurosci. 59 (2005) 280-290
50. Trost M., Carbon M., Edwards C., Ma Y., Raymond D., Mentis M.J., Moeller J.R., Bressman S.B., and Eidelberg D. Primary dystonia: is abnormal functional brain architecture linked to genotype?. Ann. Neurol. 52 (2002) 853-856
51. Trost M., Su S., Su P., Yen R.F., Tseng H.M., Barnes A., Ma Y., and Eidelberg D. Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. Neuroimage 31 (2006) 301-307
52. Warkentin S., Ohlsson M., Wollmer P., Edenbrandt L., and Minthon L. Regional cerebral blood flow in Alzheimer's disease: classification and analysis of heterogeneity. Dement. Geriatr. Cogn. Disord. 17 (2004) 207-214
53. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., Nordberg A., Backman L., Albert M., Almkvist O., Arai H., Basun H., Blennow K., de Leon M., DeCarli C., Erkinjuntti T., Giacobini E., Graff C., Hardy J., Jack C., Jorm A., Ritchie K., van Duijn C., Visser P., and Petersen R.C. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 256 (2004) 240-246